Translational Medicine in Gastroenteropancreatic Neuroendocrine Neoplasias
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Clinical Research of Cancer".
Deadline for manuscript submissions: 30 September 2025 | Viewed by 161
Special Issue Editor
Special Issue Information
Dear Colleagues,
Gastroenteropancreatic neuroendocrine tumors are a heterogeneous group of neoplasms arising from neuroendocrine cells of the gastrointestinal tract and pancreas characterized by variable growth kinetics and variable clinical courses in relation to their primary location and secretory activity. Therefore, based on their diverse biological behaviors, ranging from indolent to highly aggressive, they pose unique challenges in diagnosis and management. Despite their relative rarity, the incidence has been steadily increasing, attributed to improved diagnostic capabilities and heightened clinical awareness.
Recent advances have been mainly achieved in the field of basic sciences with the molecular profiling of tumor tissue at almost all multiomic levels. It is the aim of this review to elucidate current basic research for its applicability in the clinics. In this setting, it will be of utmost importance to show how this research will impact and improve the early detection and precise characterization of gastroenteropancreatic neuroendocrine neoplasias.
Therefore, this Special Issue aims at integrating cutting-edge technologies with an improved understanding of tumor biology, thereby moving the field closer to personalized medicine, offering hope for better prognostic stratification and tailored treatment strategies for patients with the neuroendocrine neoplasia.
Prof. Dr. Bertram Wiedenmann
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- translational medicine
- multiomics
- improved diagnostics and therapy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
